Meta Platforms stock has been slammed into classic “buy the blood” territory and analysts see 55% upside potential.
Latest Ratings for META
DateFirmActionFromTo Jul 2020DesjardinsInitiates Coverage OnBuy
Importance Rank:
1
Meta Platforms stock has been slammed into classic “buy the blood” territory and analysts see 55% upside potential.
DateFirmActionFromTo Jul 2020DesjardinsInitiates Coverage OnBuy